Mephenytoin and sparteine oxidation: genetic polymorphisms in Denmark

Br J Clin Pharmacol. 1989 May;27(5):620-5. doi: 10.1111/j.1365-2125.1989.tb03426.x.

Abstract

The oxidation of mephenytoin was polymorphic in 358 healthy Danish volunteers. The ratio between the chromatographic peak areas of (S)- and (R)-mephenytoin (S/R) in 12 h urine was less than or equal to 0.48 in 349 extensive metabolizers (EM) and greater than or equal to 1 in 9 (2.5%) poor metabolizers (PM). Concomitant intake of mephenytoin and sparteine and subsequent assay by gas chromatography had no influence on the test results (mephenytoin S/R ratio or sparteine metabolic ratio). Among ten parents and seven siblings to six unrelated PM of mephenytoin only one (1/17 = 5.9%) was a PM. The pedigrees were compatible with an autosomal recessive mode of inheritance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Chromatography, Gas
  • Denmark
  • Female
  • Humans
  • Hydantoins / metabolism*
  • Male
  • Mephenytoin / metabolism*
  • Mephenytoin / pharmacokinetics
  • Middle Aged
  • Oxidation-Reduction
  • Phenotype
  • Polymorphism, Genetic*
  • Sparteine / metabolism*
  • Sparteine / pharmacokinetics

Substances

  • Hydantoins
  • Sparteine
  • Mephenytoin